Tirzepatide vs Orforglipron: Understanding Two Distinct GLP-1 Pathway Research Approaches
Introduction As interest in metabolic signaling research continues to expand, compounds interacting with incretin pathways have become a major focus in laboratory environments. Two frequently discussed compounds in this category are Tirzepatide and Orforglipron. While both are studied in relation to GLP-1 receptor activity, they represent fundamentally different approaches—one being a peptide-based dual agonist, and…
